FR2426461A1 - Acides gras, derives de ceux-ci et medicaments qui en contiennent - Google Patents

Acides gras, derives de ceux-ci et medicaments qui en contiennent

Info

Publication number
FR2426461A1
FR2426461A1 FR7913122A FR7913122A FR2426461A1 FR 2426461 A1 FR2426461 A1 FR 2426461A1 FR 7913122 A FR7913122 A FR 7913122A FR 7913122 A FR7913122 A FR 7913122A FR 2426461 A1 FR2426461 A1 FR 2426461A1
Authority
FR
France
Prior art keywords
pharmaceutically acceptable
derivatives
fatty acids
products containing
amides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913122A
Other languages
English (en)
French (fr)
Other versions
FR2426461B1 (enrdf_load_stackoverflow
Inventor
Hans Olaf Bang
Jorn Dyerberg
John Robert Vane
Salvador Enrique Moncada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2426461A1 publication Critical patent/FR2426461A1/fr
Application granted granted Critical
Publication of FR2426461B1 publication Critical patent/FR2426461B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7913122A 1978-05-26 1979-05-23 Acides gras, derives de ceux-ci et medicaments qui en contiennent Granted FR2426461A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations
GB2357478 1978-05-26

Publications (2)

Publication Number Publication Date
FR2426461A1 true FR2426461A1 (fr) 1979-12-21
FR2426461B1 FR2426461B1 (enrdf_load_stackoverflow) 1983-02-11

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913122A Granted FR2426461A1 (fr) 1978-05-26 1979-05-23 Acides gras, derives de ceux-ci et medicaments qui en contiennent

Country Status (13)

Country Link
JP (1) JPS5515444A (enrdf_load_stackoverflow)
AU (1) AU527784B2 (enrdf_load_stackoverflow)
CA (1) CA1151068A (enrdf_load_stackoverflow)
CH (1) CH644267A5 (enrdf_load_stackoverflow)
DE (1) DE2831507A1 (enrdf_load_stackoverflow)
ES (1) ES480921A0 (enrdf_load_stackoverflow)
FR (1) FR2426461A1 (enrdf_load_stackoverflow)
IE (1) IE48287B1 (enrdf_load_stackoverflow)
IL (1) IL55227A (enrdf_load_stackoverflow)
IT (1) IT1116505B (enrdf_load_stackoverflow)
NL (1) NL191332C (enrdf_load_stackoverflow)
NZ (1) NZ187908A (enrdf_load_stackoverflow)
SE (1) SE448678B (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542613A1 (fr) * 1983-03-18 1984-09-21 Terumo Corp Emulsion liquide pour transfusion
FR2614790A1 (fr) * 1987-05-07 1988-11-10 Scras Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique
WO1993020717A3 (en) * 1992-04-13 1994-02-17 Res Corp Technologies Inc Reducing gastrointestinal irritation in infant nutrition

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
DE10056351A1 (de) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmazeutisches Präparat
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
LT3278665T (lt) 2009-04-29 2020-12-10 Amarin Pharmaceuticals Ireland Limited Stabili farmacinė kompozicija ir jos panaudojimo būdai
MY205872A (en) 2009-04-29 2024-11-18 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising omega-3 fatty acids
PT2443246T (pt) 2009-06-15 2018-03-14 Amarin Pharmaceuticals Ie Ltd Composições e métodos para reduzir os triglicéridos sem aumentar os níveis de ldl-c num indivíduo em terapia de estatinas concomitante
BR112012006692B8 (pt) 2009-09-23 2021-05-25 Amarin Corp Plc composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013103958A1 (en) 2012-01-06 2013-07-11 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
SG10201913647QA (en) 2012-06-29 2020-03-30 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
SG10201706205RA (en) 2013-02-06 2017-08-30 Agency Science Tech & Res Methods for reducing aggregate levels in protein preparations by treatment with thio-heterocyclic cations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
EP4056176B1 (en) 2018-09-24 2024-04-24 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5781M (enrdf_load_stackoverflow) * 1965-03-27 1968-02-12
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
FR2231379A1 (enrdf_load_stackoverflow) * 1973-05-30 1974-12-27 Cepbepe
DE2749492A1 (de) * 1976-11-04 1978-05-11 Bio Oil Res Antithrombosemittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6257605A (ja) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi 多元素鉱物からの有効成分抽出方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5781M (enrdf_load_stackoverflow) * 1965-03-27 1968-02-12
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
FR2231379A1 (enrdf_load_stackoverflow) * 1973-05-30 1974-12-27 Cepbepe
DE2749492A1 (de) * 1976-11-04 1978-05-11 Bio Oil Res Antithrombosemittel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/61 *
EXBK/73 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542613A1 (fr) * 1983-03-18 1984-09-21 Terumo Corp Emulsion liquide pour transfusion
FR2614790A1 (fr) * 1987-05-07 1988-11-10 Scras Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique
BE1001075A3 (fr) * 1987-05-07 1989-06-27 Sod Conseils Rech Applic Nouvelle composition ophtalmologique.
WO1993020717A3 (en) * 1992-04-13 1994-02-17 Res Corp Technologies Inc Reducing gastrointestinal irritation in infant nutrition

Also Published As

Publication number Publication date
FR2426461B1 (enrdf_load_stackoverflow) 1983-02-11
DE2831507A1 (de) 1979-11-29
NL7904144A (nl) 1979-11-28
JPS5515444A (en) 1980-02-02
ES8104983A1 (es) 1981-05-16
AU3808478A (en) 1980-01-17
DE2831507C2 (enrdf_load_stackoverflow) 1989-07-13
NL191332B (nl) 1995-01-02
ES480921A0 (es) 1981-05-16
NL191332C (nl) 1995-06-01
IT1116505B (it) 1986-02-10
NZ187908A (en) 1984-05-31
CH644267A5 (en) 1984-07-31
IE48287B1 (en) 1984-11-28
SE448678B (sv) 1987-03-16
IE791023L (en) 1979-11-26
SE7904570L (sv) 1979-11-27
CA1151068A (en) 1983-08-02
IT7947717A0 (it) 1979-01-19
IL55227A (en) 1982-12-31
AU527784B2 (en) 1983-03-24
IL55227A0 (en) 1978-09-29

Similar Documents

Publication Publication Date Title
FR2426461A1 (fr) Acides gras, derives de ceux-ci et medicaments qui en contiennent
PT64840B (fr) Procede de preparation d'esteres aralquiliques d'acide 1,4-dihydrapiridinocarboxilique a effet coronaire et antihypertensive application des memes pour la preparation de compositions pharmaceutiques a effet coronaire et antihypertensive et application de ces compositions pharmaceutiques pour le traitement de maladies de lacirculation sanguine
SE8902701D0 (sv) Fettsyrakomposition
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
DE69004817D1 (de) Zusammensetzung und Verfahren zur Behandlung von Erkrankungen.
PT79648B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darm-bereich
BE755924A (fr) Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
SE8800988L (sv) Farmaceutiska kompositioner med verkan paa hjaertat och det kardiovaskulaera systemet samt foerfarande foer framstaellning av desamma
EP0302481A3 (en) Use of free fatty acids for the manufacture of a medicament for treatment of diabetes mellitus
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
SE8800989D0 (sv) Dietary composition and process for preparing same
JPS56110679A (en) 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it
SE8800990D0 (sv) Skin-regenerating cosmetic compositon and process for preparing same
AT303703B (de) Verfahren zur Herstellung von neuen α-Aminoxycarbonyl- -hydroxamsäure-derivaten, deren optisch aktiven Isomeren und pharmazeutisch anwendbaren Säureadditionssalzen
DE3062300D1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them
AT301551B (de) Verfahren zur Herstellung von neuen (1,2,3,4-Tetrahydro-6-chinolyl)essigsäuren, deren Estern und stickstoffhaltigen Derivaten, sowie deren Isomeren, optischen Antipoden und Salzen
AT289752B (de) Verfahren zur Herstellung von neuen 4-Aminomethylbicyclo[2,2,2]octan- bzw. 4-Aminomethylbicyclo[3,2,2]nonan-1-carbonsäuren und deren 2,5-Diketoverbindungen, sowie deren Salzen, Estern und N-Alkanoylverbindungen
FR2457275A1 (fr) Acides p-biphenyl-4 methyl-2 buten-3 oiques utiles dans le traitement des rhumatismes
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
JPS56131514A (en) Ketoprofen composition for rectum administration
FR2302727A1 (fr) Nouveaux derives d'acide prostanique, leur procede de preparation et leur application en tant que medicaments
HASEGAWA et al. Hemorrhage and fibrinolysis
AT298444B (de) Verfahren zur Herstellung der neuen 4-Aminomethylbicyclo[2,2,1]heptan-1-carbonsäure und deren Salze, Ester und N-Alkanoylderivate
BE787809A (fr) Derives de l'acide phenylacetique, leur procede de preparation et composition therapeutique les contenant
AT325041B (de) Verfahren zur herstellung neuer ungesättigter, äthersubstituierter xanthoncarbonsäurederivate und deren pharmazeutisch zulässigen estern, amiden und salzen

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property